Luigi Angrisani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luigi Angrisani has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- Antonella Santonicola
Gastrointestinal Unit, Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, 84131 Salerno, Italy
13 shared publications - Paola Iovino
Gastrointestinal Unit, Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Baronissi Italy
13 shared publications - Antonio Vitiello
Department of Health Prevention, Research and Emergencies, Italian Ministry of Health, Rome, Italy
7 shared publications - Maurizio De Luca
Department of General Surgery, Rovigo Hospital, Rovigo, Italy
7 shared publications Antonella Santonicola
Gastrointestinal Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy
6 shared publications- Giampaolo Formisano
Department of Surgery, Asst Santi Paolo e Carlo, Dipartimento di Scienze della Salute, University of Milan, Milan, Italy
5 shared publications
Latest Publications
- Open Access
- 20 June 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4052-4064
Long-Term Anatomical Durability and Clinical Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair: Up to 10-Year Multicenter Analysis
Background: Hiatal hernia is common in patients with severe obesity undergoing metabolic bariatric surgery. Although concomitant hiatal hernia repair during laparoscopic sleeve gastrectomy has been widely adopted, long-term data beyond 5 years remain limited, and the clinical relevance of anatomical recurrence is still poorly defined. Objectives: To evaluate the 10-year recurrence rate, predictors of failure, and clinical outcomes following concomitant sleeve gastrectomy and hiatal hernia repair. Methods: This retrospective multicenter cohort study analyzed 111 patients who underwent sleeve gastrectomy with concomitant hiatal hernia repair between 2014 and 2015. Complete-case analysis included only patients with assessable recurrence status at follow-up. The primary outcome was anatomical recurrence (> 2 cm transhiatal migration of the gastric sleeve). Secondary outcomes included reintervention, gastroesophageal reflux disease (GERD), and weight loss. Results: Among 111 patients, 108 were analyzed. Mean age was 50.1 ± 11.6 years, 80.6% female, mean baseline BMI 42.7 ± 5.8 kg/m², and mean follow-up was 93.0 ± 22.7 months (7.7 ± 1.9 years). Hernia recurrence occurred in 14 patients (13.0%). Among these, 5 (35.7%) underwent reintervention, while 9 (64.3%) were managed conservatively. Freedom from recurrence was 98.1% at 5 years and 68.9% at 10 years, although the 10-year estimate should be interpreted cautiously. Hernia size ≥ 5 cm and postoperative GERD were associated with recurrence (OR 5.0; 95% CI 1.2-20.0; P=0.035; OR 4.97; 95% CI 1.56–17.53; p = 0.008). Reintervention was required in 11 patients (10.2%), all with symptomatic GERD. Conclusions: Concomitant sleeve gastrectomy and hiatal hernia repair were associated with acceptable long-term outcomes in this multicenter cohort. Reintervention was more often associated with postoperative reflux-related symptoms than with anatomical recurrence alone, while many anatomical recurrences were managed conservatively.
- 20 June 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4052-4064
Open AccessLong-Term Anatomical Durability and Clinical Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair: Up to 10-Year Multicenter Analysis
Background: Hiatal hernia is common in patients with severe obesity undergoing metabolic bariatric surgery. Although concomitant hiatal hernia repair during laparoscopic sleeve gastrectomy has been widely adopted, long-term data beyond 5 years remain limited, and the clinical relevance of anatomical recurrence is still poorly defined. Objectives: To evaluate the 10-year recurrence rate, predictors of failure, and clinical outcomes following concomitant sleeve gastrectomy and hiatal hernia repair. Methods: This retrospective multicenter cohort study analyzed 111 patients who underwent sleeve gastrectomy with concomitant hiatal hernia repair between 2014 and 2015. Complete-case analysis included only patients with assessable recurrence status at follow-up. The primary outcome was anatomical recurrence (> 2 cm transhiatal migration of the gastric sleeve). Secondary outcomes included reintervention, gastroesophageal reflux disease (GERD), and weight loss. Results: Among 111 patients, 108 were analyzed. Mean age was 50.1 ± 11.6 years, 80.6% female, mean baseline BMI 42.7 ± 5.8 kg/m², and mean follow-up was 93.0 ± 22.7 months (7.7 ± 1.9 years). Hernia recurrence occurred in 14 patients (13.0%). Among these, 5 (35.7%) underwent reintervention, while 9 (64.3%) were managed conservatively. Freedom from recurrence was 98.1% at 5 years and 68.9% at 10 years, although the 10-year estimate should be interpreted cautiously. Hernia size ≥ 5 cm and postoperative GERD were associated with recurrence (OR 5.0; 95% CI 1.2-20.0; P=0.035; OR 4.97; 95% CI 1.56–17.53; p = 0.008). Reintervention was required in 11 patients (10.2%), all with symptomatic GERD. Conclusions: Concomitant sleeve gastrectomy and hiatal hernia repair were associated with acceptable long-term outcomes in this multicenter cohort. Reintervention was more often associated with postoperative reflux-related symptoms than with anatomical recurrence alone, while many anatomical recurrences were managed conservatively.
- 12 June 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-12
Global Variability in Children and Adolescent Metabolic Bariatric Surgery Guidelines: A Worldwide IFSO Survey
Introduction Children and adolescent (pediatric) obesity is a growing global health challenge, with traditional weight-loss strategies often proving ineffective. Metabolic and bariatric surgery (MBS) is increasingly considered for pediatric patients with severe obesity. The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) published its latest recommendations on pediatric MBS in 2022. However, their adoption may vary across countries due to differences in healthcare systems, cultural norms, and resources. Aim To assess global variability in indications, practices, and healthcare coverage for pediatric MBS among IFSO member countries, and to evaluate adherence to international guidelines. Method A descriptive survey was conducted among IFSO-affiliated national societies using a 17-item online questionnaire covering indications for pediatric MBS, recommended techniques, referral pathways, and financial coverage. Results Of 76 societies, 66 (86.8%) responded. Most (75.8%) reported having national guidelines; 46.0% followed IFSO’s BMI-based indications’ criteria, while 14.0% applied stricter thresholds (BMI>40Kg/m2), and 8.0% did not recommend MBS outside clinical trials. Additionally, 31.8% required a minimum level of physical maturity on the basis of age, pubertal stage or bone growth. Sleeve gastrectomy was the most commonly recommended technique (69.2%). Pediatricians and parents were the most frequent referrers (35.0% and 33.0%, respectively). Some form of financial coverage was reported in 59.1% of countries, with significant disparities between regions. Conclusion Despite international recommendations, significant variability persists in pediatric MBS practices worldwide. Standardizing criteria and improving access to care are essential to ensure equitable and evidence-based treatment for children and adolescents with severe obesity.
- 12 June 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-12
Global Variability in Children and Adolescent Metabolic Bariatric Surgery Guidelines: A Worldwide IFSO Survey
Introduction Children and adolescent (pediatric) obesity is a growing global health challenge, with traditional weight-loss strategies often proving ineffective. Metabolic and bariatric surgery (MBS) is increasingly considered for pediatric patients with severe obesity. The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) published its latest recommendations on pediatric MBS in 2022. However, their adoption may vary across countries due to differences in healthcare systems, cultural norms, and resources. Aim To assess global variability in indications, practices, and healthcare coverage for pediatric MBS among IFSO member countries, and to evaluate adherence to international guidelines. Method A descriptive survey was conducted among IFSO-affiliated national societies using a 17-item online questionnaire covering indications for pediatric MBS, recommended techniques, referral pathways, and financial coverage. Results Of 76 societies, 66 (86.8%) responded. Most (75.8%) reported having national guidelines; 46.0% followed IFSO’s BMI-based indications’ criteria, while 14.0% applied stricter thresholds (BMI>40Kg/m2), and 8.0% did not recommend MBS outside clinical trials. Additionally, 31.8% required a minimum level of physical maturity on the basis of age, pubertal stage or bone growth. Sleeve gastrectomy was the most commonly recommended technique (69.2%). Pediatricians and parents were the most frequent referrers (35.0% and 33.0%, respectively). Some form of financial coverage was reported in 59.1% of countries, with significant disparities between regions. Conclusion Despite international recommendations, significant variability persists in pediatric MBS practices worldwide. Standardizing criteria and improving access to care are essential to ensure equitable and evidence-based treatment for children and adolescents with severe obesity.
- 27 February 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1932-1945
Same-day Discharge Metabolic and Bariatric Surgery: a GRADE-based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement
- 27 February 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1932-1945
Same-day Discharge Metabolic and Bariatric Surgery: a GRADE-based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement
- 26 October 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-9
Scientific production on robotic metabolic and bariatric surgery: a comprehensive bibliometric analysis on its current world status
Background: Robotic metabolic and bariatric surgery (RMBS) has emerged as an innovative approach in the treatment of severe obesity by combining the ergonomic precision of robotic technology and instrumentation with the established benefits of weight loss surgery. This study employs a bibliometric approach to identify local research trends and worldwide patterns in RMBS. Materials & Methods: The research methodology used “robotic” and “metabolic” or “bariatric surgery” to search Web of Science. Articles that were published prior to December 31st, 2023, were included. The analyses were developed using the Rayyan and Bibliometric, in R Studio. Results: 265 articles from 51 different journals were included. Scientific production of RMBS experienced a significant annual growth rate of 21.96% from 2003 to 2023, resulting in an average of 12.6 papers published per year. A high correlation (R2 = 0.94) was found between the year and number of articles. The mean number of citations per document was 13.25. Approximately 90% of the journals were classified as zone 3, according to the Bradford categorization. International collaboration was identified in 10.57% of cases, with the University of California and the University of Illinois being the most common organizations. The countries with the highest number of corresponding authors, in descending order, were the United States of America, China, and Switzerland. Conclusion: Scientific production in RMBS has experienced sustained growth since the first original publications in 2003. While it has not yet reached the volume, impact, and international collaboration seen in studies related to non-robotic metabolic and bariatric surgery, RBMS holds potential that remains to be explored. Graphical abstract
- 26 October 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-9
Scientific production on robotic metabolic and bariatric surgery: a comprehensive bibliometric analysis on its current world status
Background: Robotic metabolic and bariatric surgery (RMBS) has emerged as an innovative approach in the treatment of severe obesity by combining the ergonomic precision of robotic technology and instrumentation with the established benefits of weight loss surgery. This study employs a bibliometric approach to identify local research trends and worldwide patterns in RMBS. Materials & Methods: The research methodology used “robotic” and “metabolic” or “bariatric surgery” to search Web of Science. Articles that were published prior to December 31st, 2023, were included. The analyses were developed using the Rayyan and Bibliometric, in R Studio. Results: 265 articles from 51 different journals were included. Scientific production of RMBS experienced a significant annual growth rate of 21.96% from 2003 to 2023, resulting in an average of 12.6 papers published per year. A high correlation (R2 = 0.94) was found between the year and number of articles. The mean number of citations per document was 13.25. Approximately 90% of the journals were classified as zone 3, according to the Bradford categorization. International collaboration was identified in 10.57% of cases, with the University of California and the University of Illinois being the most common organizations. The countries with the highest number of corresponding authors, in descending order, were the United States of America, China, and Switzerland. Conclusion: Scientific production in RMBS has experienced sustained growth since the first original publications in 2003. While it has not yet reached the volume, impact, and international collaboration seen in studies related to non-robotic metabolic and bariatric surgery, RBMS holds potential that remains to be explored. Graphical abstract
- Open Access
- 28 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5106
Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects
Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
- 28 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5106
Open AccessDevelopment of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects
Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
- Top Cited PapersOpen Access
- 12 June 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (11) , 991-1025
Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS)
- 12 June 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (11) , 991-1025
Top Cited PapersOpen AccessScientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS)
- Top Cited PapersOpen Access
- 4 March 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (4) , 1075-1085
IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures
Purpose: This IFSO survey aims to describe the current trends of metabolic and bariatric surgery (MBS) reporting on the number and types of surgical and endoluminal procedures performed in 2020 and 2021, in the world and within each IFSO chapter. Methods: All national societies belonging to IFSO were asked to complete the survey form. The number and types of procedures performed (surgical and endoluminal interventions) from 2020 to 2021 were documented. A special section focused on the impact of COVID-19, the existence of national protocols for MBS, the use of telemedicine, and any mortality related to MBS. A trend analysis of the data, both worldwide and within each IFSO chapter, was also performed for the period between 2018 and 2021. Results: Fifty-seven of the 74 (77%) IFSO national societies submitted the survey. Twenty-four of the 57 (42.1%) reported data from their national registries. The total number of surgical and endoluminal procedures performed in 2020 was 507,806 and in 2021 was 598,834. Sleeve gastrectomy (SG) remained the most performed bariatric procedure. Thirty national societies (52%) had regional protocols for MBS during COVID-19, 61.4% supported the use of telemedicine, and only 47.3% collected data on mortality after MBS in 2020. These percentages did not significantly change in 2021 (p > 0.05). Conclusions: The number of MBS markedly decreased worldwide during 2020. Although there was a positive trend in 2021, it did not reach the values obtained before the COVID-19 pandemic. SG continued to be the most performed operation. Adjustable gastric banding (AGB) continues to decrease worldwide. Graphical
- 4 March 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (4) , 1075-1085
Top Cited PapersOpen AccessIFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures
Purpose: This IFSO survey aims to describe the current trends of metabolic and bariatric surgery (MBS) reporting on the number and types of surgical and endoluminal procedures performed in 2020 and 2021, in the world and within each IFSO chapter. Methods: All national societies belonging to IFSO were asked to complete the survey form. The number and types of procedures performed (surgical and endoluminal interventions) from 2020 to 2021 were documented. A special section focused on the impact of COVID-19, the existence of national protocols for MBS, the use of telemedicine, and any mortality related to MBS. A trend analysis of the data, both worldwide and within each IFSO chapter, was also performed for the period between 2018 and 2021. Results: Fifty-seven of the 74 (77%) IFSO national societies submitted the survey. Twenty-four of the 57 (42.1%) reported data from their national registries. The total number of surgical and endoluminal procedures performed in 2020 was 507,806 and in 2021 was 598,834. Sleeve gastrectomy (SG) remained the most performed bariatric procedure. Thirty national societies (52%) had regional protocols for MBS during COVID-19, 61.4% supported the use of telemedicine, and only 47.3% collected data on mortality after MBS in 2020. These percentages did not significantly change in 2021 (p > 0.05). Conclusions: The number of MBS markedly decreased worldwide during 2020. Although there was a positive trend in 2021, it did not reach the values obtained before the COVID-19 pandemic. SG continued to be the most performed operation. Adjustable gastric banding (AGB) continues to decrease worldwide. Graphical
- 2 February 2023
- Published by Springer Nature
- p. 761-769
Revisional Surgery after Laparoscopic Adjustable Gastric Banding
- 2 February 2023
- Published by Springer Nature
- p. 761-769
Revisional Surgery after Laparoscopic Adjustable Gastric Banding
- Open Access
- 25 January 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (3) , 940
Novel Impedance-pH Parameters in Pre-Bariatric Assessment of Patients: A Pilot Study
Novel impedance-pH parameters, Mean Nocturnal Baseline Impedance (MNBI) and Post-Reflux Swallow-Induced Peristaltic Wave (PSPW) index, have been proposed to improve the gastro-esophageal reflux disease (GERD) diagnostic yield. This study aims to determine the integrity of the esophageal epithelial barrier and chemical clearance using these novel parameters and to correlate them with acid exposure time (AET) and acid clearance time (ACT) in obese patients who are candidates for bariatric surgery (BS). Twenty impedance-pHmetry tracings of patients prior to BS were reviewed. Nine (45%) patients with a conclusive diagnosis of GERD had significantly higher ACT, lower MNBI in the distal esophagus and lower PSPW indexes compared to obese patients without GERD. Moreover, 100% of obese patients with GERD had a pathological ACT compared to obese patients without GERD (p = 0.003). However, the percentage of pathological MNBI and PSPW index did not differ between obese patients with and without GERD. The PSPW index and MNBI of the distal channel significantly correlated with ACT and AET. Further studies are needed to assess the role of time-consuming novel parameters in the routine evaluation of morbidly obese patients candidates for BS. The value of acid clearance time is confirmed as a relevant impedance-pH parameter in these patients.
- 25 January 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (3) , 940
Open AccessNovel Impedance-pH Parameters in Pre-Bariatric Assessment of Patients: A Pilot Study
Novel impedance-pH parameters, Mean Nocturnal Baseline Impedance (MNBI) and Post-Reflux Swallow-Induced Peristaltic Wave (PSPW) index, have been proposed to improve the gastro-esophageal reflux disease (GERD) diagnostic yield. This study aims to determine the integrity of the esophageal epithelial barrier and chemical clearance using these novel parameters and to correlate them with acid exposure time (AET) and acid clearance time (ACT) in obese patients who are candidates for bariatric surgery (BS). Twenty impedance-pHmetry tracings of patients prior to BS were reviewed. Nine (45%) patients with a conclusive diagnosis of GERD had significantly higher ACT, lower MNBI in the distal esophagus and lower PSPW indexes compared to obese patients without GERD. Moreover, 100% of obese patients with GERD had a pathological ACT compared to obese patients without GERD (p = 0.003). However, the percentage of pathological MNBI and PSPW index did not differ between obese patients with and without GERD. The PSPW index and MNBI of the distal channel significantly correlated with ACT and AET. Further studies are needed to assess the role of time-consuming novel parameters in the routine evaluation of morbidly obese patients candidates for BS. The value of acid clearance time is confirmed as a relevant impedance-pH parameter in these patients.